GSK

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change -0.30
Percentage change -0.81	%

Peers: JNJ PFE MRK BMY LLY NVS AZN ABBV SNY GILD

| Held by: FVD GCOW PPH AVDE FENI RODM DFAX BINV AVIV PLDR

Scroll to Statements

Index	-	P/E	19.14	EPS (ttm)	1.93	Insider Own	0.00%	Shs Outstand	2.04B	Perf Week	-4.85%
Market Cap	74.70B	Forward P/E	7.59	EPS next Y	4.86	Insider Trans	-	Shs Float	2.03B	Perf Month	8.03%
Income	3.98B	PEG	2.11	EPS next Q	1.15	Inst Own	16.76%	Short Float	0.81%	Perf Quarter	1.35%
Sales	40.23B	P/S	1.86	EPS this Y	9.03%	Inst Trans	-3.97%	Short Ratio	2.93	Perf Half Y	-0.27%
Book/sh	8.95	P/B	4.12	EPS next Y	11.74%	ROA	5.23%	Short Interest	16.39M	Perf Year	-15.14%
Cash/sh	2.86	P/C	12.90	EPS next 5Y	9.08%	ROE	22.26%	52W Range	31.72 - 45.92	Perf YTD	9.02%
Dividend Est.	1.73 (4.70%)	P/FCF	11.79	EPS past 5Y	-11.63%	ROI	10.07%	52W High	-19.72%	Beta	0.52
Dividend TTM	1.56 (4.24%)	Quick Ratio	0.58	Sales past 5Y	-0.74%	Gross Margin	71.84%	52W Low	16.25%	ATR (14)	0.97
Dividend Ex-Date	May 16, 2025	Current Ratio	0.87	EPS Y/Y TTM	-29.96%	Oper. Margin	18.02%	RSI (14)	46.01	Volatility	2.17% 2.54%
Employees	68629	Debt/Eq	1.30	Sales Y/Y TTM	4.17%	Profit Margin	9.89%	Recom	2.77	Target Price	43.65
Option/Short	Yes / Yes	LT Debt/Eq	1.16	EPS Q/Q	53.31%	Payout	94.89%	Rel Volume	1.06	Prev Close	37.17
Sales Surprise	3.33%	EPS Surprise	14.83%	Sales Q/Q	1.38%	Earnings	Apr 30 BMO	Avg Volume	5.59M	Price	36.87
SMA20	-0.44%	SMA50	-2.58%	SMA200	-2.08%	Trades		Volume	5,942,547	Change	-0.81%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-15-25	Initiated	Exane BNP Paribas	Neutral	$35.25
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Nov-15-24	Downgrade	Deutsche Bank	Buy → Hold
Nov-12-24	Downgrade	Jefferies	Buy → Hold	$53 → $39.50
Oct-31-24	Downgrade	Guggenheim	Buy → Neutral
Jul-08-24	Downgrade	UBS	Buy → Neutral
May-30-24	Initiated	Goldman	Neutral	$47
Mar-04-24	Upgrade	Guggenheim	Neutral → Buy
Feb-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$44
Jan-16-24	Resumed	UBS	Buy
Jan-03-24	Upgrade	Jefferies	Hold → Buy	$48
Jul-14-23	Initiated	HSBC Securities	Reduce
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight
Dec-05-22	Downgrade	BofA Securities	Neutral → Underperform
Nov-11-22	Downgrade	UBS	Neutral → Sell
Sep-15-22	Upgrade	Credit Suisse	Underperform → Neutral
Sep-08-22	Downgrade	Jefferies	Buy → Hold	$50.50 → $34

Show Previous Ratings

May-07-25 11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
May-06-25 09:54AM	Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1 (Zacks)
May-05-25 11:37AM	5 Reasons GSK Looks Good (Seeking Alpha)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
03:04AM	European Firms Fare Better Than Feared Through Early Trade Pain (Bloomberg)
11:22AM	Loading…
May-01-25 11:22AM	Moderna Beats on Q1 Earnings, Lags on Revenues, Focuses on Cost Cuts (Zacks)
11:01AM	GSK PLC (GSK) Q1 2025 Earnings Call Highlights: Strong Specialty Medicines Growth Amid Vaccine ... (GuruFocus.com)
09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
06:46AM	Analyst Report: GSK plc (Morningstar Research)
12:47AM	US risks recession as economy shrinks in tariff war (The Telegraph)
Apr-30-25 04:27PM	GSK Jumps On Solid Earnings, Says It's 'Well Positioned' To Navigate Tariffs (Investor's Business Daily)
12:32PM	GSK plc (GSK) Q1 2025 Earnings Conference Call Transcript (Seeking Alpha)
11:45AM	GSK Q1 Earnings Beat, Sales Lag, Stock Gains on Tariff Reassurance (Zacks)
11:05AM	Tariff turmoil prompts cloudy forecasts from companies for the year ahead (Associated Press Finance)
09:50AM	Here's Why GSK (GSK) is a Strong Momentum Stock (Zacks)
09:09AM	Loading…
09:09AM	Should You Buy, Sell or Hold GILD Stock Post Q1 Earnings Miss? (Zacks)
08:51AM	GSK Posts Strong Results, Says 'Well Positioned' in Case of Pharma Tariffs (Investopedia)
07:05AM	GSK (GSK) Q1 Earnings Surpass Estimates (Zacks)
03:07AM	GSK Sales, Profit Rise on Boost from HIV, Cancer Drugs (The Wall Street Journal)
Apr-29-25 03:46PM	SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO (Seeking Alpha)
Apr-28-25 09:14AM	GSK to Report First-Quarter Earnings: Is a Beat in Store? (Zacks)
Apr-25-25 04:30PM	Is GSK plc (GSK) the Best Undervalued UK Stock to Buy Right Now? (Insider Monkey)
10:41AM	GILD Down on Q1 Earnings and Sales Miss, Oncology Sales Decline (Zacks)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Apr-24-25 10:01AM	Earnings Preview: Alnylam Pharmaceuticals (ALNY) Q1 Earnings Expected to Decline (Zacks)
Apr-23-25 05:48PM	Shingles Vaccine Appears to Lower Dementia Risk (The Wall Street Journal)
02:50PM	Why vaccine makers aren't worried about Trump administration cuts (Yahoo Finance)
10:01AM	Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-21-25 04:49PM	Top Research Reports for Visa, ServiceNow & Progressive (Zacks)
Apr-20-25 11:28AM	IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (Seeking Alpha)
03:31PM	Loading…
Apr-17-25 03:31PM	US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years (Benzinga)
02:10PM	UK Becomes First Country To Authorize Blenrep In Two Combo Regimens (Benzinga)
01:06PM	Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings? (Zacks)
09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
09:20AM	GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59 (Zacks)
09:17AM	GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP (Zacks)
08:00AM	Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimers Disease (GlobeNewswire)
Apr-16-25 05:36PM	AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices (Business Wire)
04:57PM	GSKs 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices (Business Wire)
08:54AM	Dodge & Cox International Stock Fund Q1 2025 Shareholder Letter (Seeking Alpha)
07:20AM	Dodge & Cox Balanced Fund Q1 2025 Shareholder Letter (Seeking Alpha)
06:28AM	Dodge & Cox Global Stock Fund Q1 2025 Shareholder Letter (Seeking Alpha)
Apr-09-25 03:59PM	Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out (Seeking Alpha)
12:57PM	3 Biotech Stocks Holding Their Own (Seeking Alpha)
12:03PM	Top Stock Movers Now: Delta, Apple, Eli Lilly, and More (Investopedia)
10:28AM	Pharma Stocks Sink as Trump Says 'Major' Tariffs Coming to Industry (Investopedia)
10:00AM	GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025 (Business Wire)
08:17AM	Novo Nordisk, AbbVie, Other Stocks Tumble After Trump Threatens Pharma Tariffs (The Wall Street Journal)
06:17AM	Pharma Stocks Drop After Trump Threatens Tariffs on Medicines (The Wall Street Journal)
05:00AM	Barbara Weber, M.D., Elected to ITM Supervisory Board (GlobeNewswire)
Apr-07-25 04:45PM	Bavarian Nordic Trading At Great Value Levels With Upbeat 2025 Outlook (Seeking Alpha)
01:46PM	Investors in GSK plc Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights GSK (GlobeNewswire)
Apr-04-25 02:00PM	New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops (Benzinga) -6.36%
Apr-03-25 06:03PM	GSK resolves patent lawsuit against Pfizer over RSV vaccines (Reuters)
10:28AM	Spirits, Swiss Watches, Sneakers: Global Stock-Market Winners and Losers from Tariffs (The Wall Street Journal)
Apr-02-25 03:35PM	GSK: Under Threat From 'Double Whammy' Of Vaccine Skepticism And Pharma Tariffs (Seeking Alpha)
12:10PM	Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
07:37AM	PFE Secures EU Nod for Expanded Use of RSV Vaccine Abrysvo (Zacks)
Apr-01-25 09:59AM	Is GSK plc (GSK) the Most Undervalued Healthcare Stock to Buy According to Analysts? (Insider Monkey)
09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
05:45AM	Shareholders of GSK plc Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK (PR Newswire)
Mar-31-25 05:15PM	FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade) (Seeking Alpha)
09:31AM	Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out (The Wall Street Journal)
Mar-28-25 05:19PM	Is GSK plc (GSK) the Best ADR Stock to Buy According to Hedge Funds? (Insider Monkey)
04:00PM	China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market (Investor's Business Daily)
Mar-27-25 03:54PM	Wave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531 (SeekingAlpha)
02:44PM	Analyst Report: GSK plc (Morningstar Research)
11:30AM	U.S. to end funding for child vaccines in developing countries, NY Times reports (TipRanks)
10:44AM	Jim Cramer Says 'Buy and Put Away' GSK (GSK) for Its 4% Yield (InsiderMonkey)
08:31AM	IONS Out-Licenses ex-U.S. Rights for Rare Disease Drug Tryngolza to Sobi (Zacks)
Mar-26-25 06:43PM	U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine (The Wall Street Journal)
10:02AM	Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More (Zacks)
09:01AM	ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program (PR Newswire)
07:58AM	GSK Secures FDA Nod for Oral Antibiotic to Treat Urinary Tract Infection (Zacks)
Mar-25-25 06:15PM	Blujepa (gepotidacin) Approved by US FDA for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) in Female Adults and Pediatric Patients 12 Years of Age and Older (Business Wire)
05:09PM	Top Research Reports for Microsoft, NVIDIA & Alphabet (Zacks)
06:20AM	Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? (Zacks)
Mar-24-25 02:36PM	EMA Accepts GSK's Filing for Expanded Use of Nucala in COPD (Zacks)
Mar-20-25 05:49PM	Former Texas congressman Burgess eyed as CDC director nominee - report (SeekingAlpha)
03:00PM	GILD Stock Down on Report of Cut in HIV Prevention Spending (Zacks)
02:11PM	U.S. boosts bird flu response with another $100M in funds (SeekingAlpha)
10:32AM	GSK Stock Recovers, Rises Around 17% YTD: Time to Buy, Sell or Hold? (Zacks)
10:00AM	Trump Trade: Reciprocal tariffs still to start on April 2 (TipRanks)
08:45AM	Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B (Zacks)
Mar-19-25 11:45AM	Stocks to Watch Wednesday: Nvidia, Shopify, Williams-Sonoma, Tesla (The Wall Street Journal)
10:50AM	HIV Drug Makers Get Spooked by Possible Trump Cut, but Impact Looks Manageable (The Wall Street Journal)
10:29AM	Why GSK plc (GSK) Is Among the Most Undervalued Biotech Stocks to Invest In (Insider Monkey)
09:39AM	Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant (GuruFocus.com)
09:37AM	Gilead Stock Falls on Report U.S. Could Slash HIV-Prevention Budget (The Wall Street Journal)
04:41AM	Pfizer Wraps Up Haleon Exit With $3.3 Billion Stake Sale (Bloomberg)
Mar-18-25 11:05AM	Jim Cramer Likes This Healthcare Dividend Stock With 4% Yield (Insider Monkey)
Mar-17-25 05:00AM	Pfizer Has a New Playbook for Reviving Salesand Its Starting to Pay Off (The Wall Street Journal)
Mar-08-25 03:45AM	Power Players: Meet the women reshaping 10 key European industries (Fortune)
Mar-07-25 04:04PM	Why Moderna Stock Has Surged 15% This Week Despite Mixed News (Investor's Business Daily)
11:30AM	Glaxo (GSK) Up 8% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-06-25 04:12AM	Jim Cramer Says GSK plc (GSK) Is A Very Inexpensive Stock With A 4% Yield (Insider Monkey)
Mar-04-25 02:20PM	GSK's Once-Daily Inhalers For Smoker's Lung Has Potential Benefits: Independent Organization Report (Benzinga)
05:45AM	GSK plc Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK (PR Newswire)

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GSK plc	10% Owner	Sep 27 '24	Buy	8.00	2,791,930	22,335,440	16,775,691	Oct 01 05:54 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GSK Plc ADR

Upgrade your FINVIZ experience